These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2658581)
1. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Peterson LR; Lissack LM; Canter K; Fasching CE; Clabots C; Gerding DN Am J Med; 1989 Jun; 86(6 Pt 2):801-8. PubMed ID: 2658581 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Valtonen V; Karppinen L; Kariniemi AL Scand J Infect Dis Suppl; 1989; 60():79-83. PubMed ID: 2547245 [TBL] [Abstract][Full Text] [Related]
3. Use of intravenous ciprofloxacin in difficult-to-treat infections. Giamarellou H; Galanakis N Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059 [TBL] [Abstract][Full Text] [Related]
4. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group. Modai J Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426 [TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections. Peacock JE; Pegram PS; Weber SF; Leone PA Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin: an update on clinical experience. Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063 [TBL] [Abstract][Full Text] [Related]
8. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029 [TBL] [Abstract][Full Text] [Related]
9. Treatment of serious infections with intravenous ciprofloxacin. Scully BE; Neu HC Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045 [TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. LeBel M Pharmacotherapy; 1988; 8(1):3-33. PubMed ID: 2836821 [TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042 [TBL] [Abstract][Full Text] [Related]
13. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections. Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418 [TBL] [Abstract][Full Text] [Related]
15. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Fass RJ; Plouffe JF; Russell JA Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361 [TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial. Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049 [TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections. Levine DP; McNeil P; Lerner SA Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650 [TBL] [Abstract][Full Text] [Related]